Manmeet Ahluwalia

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Seagen
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Novocure
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Kiyatec
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Insightec
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    GSK
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Xoft
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Nuvation
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Cellularity
    Date added:
    08/08/2023
    Date updated:
    08/08/2023
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    SDP Oncology
    Date added:
    08/08/2023
    Date updated:
    08/08/2023

Pages

Return to 2023 Annual Symposium For Evolving Therapies and Drug Development in Oncology: Targeted therapy, immunotherapy and beyond